Results for 'clinical data'
Kirk Shepard
How Cross-Functional Teams Reshape Cancer Care
Jay Fine, Preclinical Research, Early Stage
In episode 3 of Oncology Voice Network Podcast, Dr. Kirk Shepard sits down with Dr. Jay Fine, a renowned immunologist and President of R&D at Evolve Immune Therapeutics and a Forbes-published author in Voices of Oncology, for a candid look at how discovery truly connects to patient care.
Feb 17th • 23 mins listen
MSL Talk: Tom Caravela, Jessica Johnson, Whitney Theiss
The Path from Clinical Practice to Field Medical (MSL, CSL or CPL)
Clinical Practice Liaison, Field Medical Positions, Medical Science Liaisons, Transition to Industry, Emotional Intelligence in Healthcare
In this episode, Jessica Johnson and Whitney Theiss from Neurocrine Biosciences join Tom Caravela to explore the transition from clinical roles to field medical positions, focusing on the Clinical Practice Liaison (CPL) role. They discuss the responsibilities and skills required for CPLs, compa…
Mar 30th • 35 mins listen
MSL Talk: Tom Caravela, Brad Atkinson, Brian Wilson, Christina Wright
How and Why Medical Affairs Can Support Diversity in Clinical Trials
diversity in clinical trials, role of MSLs, FDA guidance on diversity, patient-centric approaches, cultural awareness and allyship
In this episode, Tom Caravela is joined by Brad Atkinson, Brian Wilson, and Christina Wright to explore the critical role of diversity in clinical trials and the MSL’s part in fostering inclusivity. The discussion covers FDA guidance on diversity, challenges in therapeutic areas, and the …
Aug 24th • 42 mins listen
MSL Talk: Tom Caravela, Ryan Norman
Engagement Strategies: Crafting Your Story to Clinical Professionals
pharmaceutical industry, clinical expertise, business insights, MSL role, virtual engagements
In this episode, Ryan Norman joins Tom Caravela to discuss his journey into the pharmaceutical industry and how he successfully blended clinical expertise with business insights in his role as an MSL. Ryan delves into effective strategies for preparing for KOL meetings, aligning messaging with …
Sep 14th • 31 mins listen
MSL Talk: Tom Caravela, Carrie Caretta, Giancarlo Maranzano
The Misalignment of Clinical Development and Field Medical Affairs
clinical development, field medical affairs, MSLs recruitment, pharmaceutical strategies, Boehringer Ingelheim
In this episode, Tom Caravela is joined by Carrie Caretta and Giancarlo Maranzano from Boehringer Ingelheim to explore the integration of clinical development and field medical affairs. They discuss the strategic role of field medical teams in clinical trial recruitment and how MSLs can effecti…
Mar 22nd • 29 mins listen
MSL Talk: Tom Caravela, Khalil Ahmed
Evolving Role of MSL Field Support for Clinical Trials
Medical Science Liaisons, clinical trials, MSL involvement, Syneos Health, Khalil Ahmed
In this episode, Tom Caravela is joined by Khalil Ahmed to explore the integral role of Medical Science Liaisons (MSLs) in clinical trials. Khalil shares his background and discusses the significant impact MSLs have on site selection, recruitment, and training. The conversation delves into the …
Apr 4th • 34 mins listen
MSL Talk: Tom Caravela, Michelle Offner
The Evolving Role of Clinical Educators for Pharma and Field Medical
clinical educator, medical field, clinical education, networking, health outcomes
In this episode, Michelle Offner shares her journey from her previous roles to becoming a clinical educator. She delves into the responsibilities and importance of clinical educators, highlighting the skills and value they bring to the medical field. Michelle discusses the challenges faced in this r…
Sep 17th • 26 mins listen
MSL Talk: Tom Caravela, Jeff Vaughn, Dean McAllister
Is it Ever Too Early or Too Late
Medical Science Liaison, drug development, early MSL engagement, clinical trial planning, strategic prioritization
In this episode, Tom Caravela is joined by Jeff Vaughn and Dean McAllister to discuss the critical timing of Medical Science Liaison (MSL) involvement in drug development. They explore misconceptions and historical approaches, highlighting the impact and internal value of early MSL engagement. The c…
Feb 18th • 34 mins listen
MSL Talk: Tom Caravela, Maria Abunto
From Clinical to Medical Device MSL and Beyond
Medical Science Liaison, MSL roles, medical device industry, transitioning MSL, International MSL Day
In this episode, Maria Abunto joins Tom Caravela to discuss her journey from clinical practice to becoming a successful Medical Science Liaison (MSL) in the medical device industry. Maria shares insights on why clinicians are well-suited for MSL roles and the importance of mentors and career co…
Apr 20th • 28 mins listen
Asco Daily News Podcast
New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity
Drs. Shaalan Beg and Travis Osterman discuss a machine learning model, recently featured in JCO Clinical Cancer Informatics, that uses electronic health record data to accurately predict the effectiveness and toxicity of treatment with immune checkpoint inhibitors. The new AI model can be use…
Mar 21st • 16 mins listen
Monty Pal
Building the First AI Agent for Cancer Research
City of Hope, Monty Pal, Enrique Velazquez Villarreal, Latino, colorectal cancer, mentor, genomics, AI, artificial intelligence, multiomic
Dr. Enrique Velazquez Villarreal on AI, genomics, and why young Latinos are at the heart of his work to improve colorectal cancer research and care.
May 5th • 49 mins listen
Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
Labcorp, Rebecca Previs, Heidi Ko, HER2, NGS, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker, ERBB2, IHC, FISH, biomarker
What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Jun 8th • 20 mins listen
Rebecca Previs
Rethinking How We Track and Treat Cancer
Labcorp, Rebecca Previs, Michelle Green, genomics, ASCO, HER2, HER3, MRD, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, ctDNA, biomarker
HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.
Jul 13th • 19 mins listen
Michael Pietrack
Aspiring MSL Insight: Do You Have a Back-Pocket Presentation?
If you’re an aspiring MSL, you’re probably thinking a lot about how to master the MSL interview. 🎤 The biggest part of the interview is the presentation you’ll give during the final interview. 📊 One way to really shine on this very important element of the evaluation process …
Jul 22nd • 3 mins listen
Michael Pietrack
Aspiring MSL Insight: What Types of MSL Presentations are Acceptable in a Final Interview?
Aspiring MSL Insight: What Types of MSL Presentations are Acceptable in a Final Interview? 🧑‍⚕️🎤 If you’re an Aspiring MSL, you likely realize how important the MSL presentation is during the final interview. But you may be wondering, “What type of presentation should…
Aug 9th • 3 mins listen
Michael Pietrack
Season 1, Episode 18: Challenges Facing the Pharma Universe with Jack West
In this episode of the Pharmaverse podcast, host Michael Pietrack interviews Jack West, the VP of Clinical Development at Summit Therapeutics. They discuss Jack's transition from being a practicing oncologist to working in the pharmaceutical industry, the importance of collaborations with pharm…
Sep 9th • 35 mins listen